Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 06, 2024

SELL
$306.88 - $380.0 $1.08 Million - $1.34 Million
-3,534 Reduced 23.42%
11,558 $4.37 Million
Q3 2023

Oct 10, 2023

BUY
$315.92 - $397.36 $542,118 - $681,869
1,716 Added 12.83%
15,092 $4.8 Million
Q2 2023

Jul 26, 2023

BUY
$346.15 - $392.09 $1.6 Million - $1.82 Million
4,635 Added 53.03%
13,376 $5.13 Million
Q1 2023

Apr 12, 2023

BUY
$323.56 - $373.36 $131,688 - $151,957
407 Added 4.88%
8,741 $3.26 Million
Q4 2022

Jan 24, 2023

BUY
$248.67 - $334.17 $441,637 - $593,485
1,776 Added 27.08%
8,334 $0
Q3 2022

Oct 13, 2022

BUY
$263.81 - $337.27 $10,552 - $13,490
40 Added 0.61%
6,558 $1.79 Million
Q2 2022

Jul 28, 2022

BUY
$301.4 - $428.42 $166,975 - $237,344
554 Added 9.29%
6,518 $2.08 Million
Q1 2022

May 05, 2022

SELL
$379.46 - $424.54 $1.07 Million - $1.2 Million
-2,815 Reduced 32.07%
5,964 $2.5 Million
Q4 2021

Jan 24, 2022

BUY
$373.53 - $434.12 $3.28 Million - $3.81 Million
8,779 New
8,779 $3.67 Million

Others Institutions Holding COO

About COOPER COMPANIES, INC.


  • Ticker COO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 49,346,000
  • Market Cap $4.62B
  • Description
  • The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses corr...
More about COO
Track This Portfolio

Track National Bank Of Canada Portfolio

Follow National Bank Of Canada and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of National Bank Of Canada , based on Form 13F filings with the SEC.

News

Stay updated on National Bank Of Canada with notifications on news.